SEC 13F Intelligence

Mn Services Vermogensbeheer B.V. / VRTX

Mn Services Vermogensbeheer B.V.’s Vertex Pharmaceuticals Inc Position

Does Mn Services Vermogensbeheer B.V. own Vertex Pharmaceuticals Inc (VRTX)? Not currently — the last reported position was 121.5K shares worth $49M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$49M
Q4 2023
Shares
121.5K
% of Portfolio
+0.45%
Quarters Held
20
position exited

Position History VRTX

Reported value by quarter
Q4 ’18: $6MQ4 ’18Q1 ’19: $8MQ2 ’19: $24MQ3 ’19: $38MQ3 ’19Q4 ’19: $51MQ1 ’20: $52MQ2 ’20: $64MQ2 ’20Q3 ’20: $61MQ4 ’20: $54MQ2 ’21: $32MQ2 ’21Q3 ’21: $35MQ4 ’21: $44MQ1 ’22: $49MQ1 ’22Q2 ’22: $42MQ3 ’22: $41MQ4 ’22: $36MQ4 ’22Q1 ’23: $40MQ2 ’23: $43MQ3 ’23: $44MQ3 ’23Q4 ’23: $49Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 2023121.5K$49M+0.45%
Q3 2023125.9K$44M+0.42%
Q2 2023122.7K$43M+0.40%
Q1 2023126.2K$40M+0.41%
Q4 2022123.4K$36M+0.40%
Q3 2022141.8K$41M+0.43%
Q2 2022149.6K$42M+0.39%
Q1 2022186.7K$49M+0.32%
Q4 2021198.4K$44M+0.26%
Q3 2021193.6K$35M+0.22%
Q2 2021190.7K$32M+0.25%
Q4 2020229.2K$54M+0.38%
Q3 2020224.8K$61M+0.48%
Q2 2020220.9K$64M+0.55%
Q1 2020218.7K$52M+0.58%
Q4 2019232.5K$51M+0.43%
Q3 2019226.6K$38M+0.36%
Q2 2019131.1K$24M+0.28%
Q1 201944.0K$8M+0.09%
Q4 201843.4K$6M+0.10%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mn Services Vermogensbeheer B.V.’s full portfolio or all institutional holders of VRTX.